SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019).
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Identificadores![](/xmlui/themes/Mirage2//images/despl_identif.png)
Identificadores
Visualización o descarga de ficheros![](/xmlui/themes/Mirage2//images/despl_contenidos.png)
Visualización o descarga de ficheros
Fecha de publicación
2020Título de revista
Clinical & Translational Oncology
Tipo de contenido
Journal Article
DeCS
ensayos clínicos como asunto | tromboembolia venosa | humanos | guías de práctica clínica como asunto | neoplasias | guíaMeSH
Clinical Trials as Topic | Guideline | Humans | Venous Thromboembolism | Practice Guidelines as Topic | NeoplasmsResumen
In 2011, the Spanish Society of Medical Oncology (SEOM) first published a clinical guideline of venous thromboembolism (VTE) and cancer. This guideline was updated in 2014, and since then, multiple studies and clinical trials have changed the landscape of the treatment and prophylaxis of VTE in cancer patients. To incorporate the most recent evidence, including data from direct oral anticoagulants (DOACs) randomized clinical trials, SEOM presents a new update of the guideline.
![](/xmlui/themes/Mirage2//images/final_lines.png)